SimcoDerm Clinical Trials is currently recruiting for a clinical trial with an investigational injection treatment for
atopic dermatitis (AD).

Who Can Participate?

Adults 18-75 with eczema, also known as atopic dermatitis (AD).

Inclusion Criteria

• Clinical diagnosis of moderate or severe AD for at least 1 year
• Body surface area (BSA) involvement of AD of 10% or more*
• Have stopped a biologic treatment (due to non-response, partial response, loss of efficacy, intolerance, cost, or lack of access) OR
• Have had inadequate response to prescription topical medications in the past 6 months, or for whom they are not tolerated or are
medically inadviseable

* 1% of your body surface area is roughly equal to the palm of your hand (no wrists or fingers).

What Are The Benefits?

• No cost to participate or receive treatment
• Regular visits with study doctors who specialise in treating AD (16 visits)
• Will receive either an investigative subcutaneous injection treatment (study drug) or a placebo
• Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
• 32 weeks